What was recalled
The U.S. Food and Drug Administration (FDA) has issued a Class II recall involving specific medical supplies distributed by AVID Medical, Inc. This action targets the Halyard IV Start Kit Non-Sterile, identified specifically by the reference number KRIV26-02. To understand the scope of this recall, it is helpful to look at exactly what these kits are and how they function in a clinical setting. These convenience kits are designed to streamline the process of initiating intravenous therapy by bundling essential components into a single package. Typically, an IV start kit includes items like alcohol swabs, antiseptic prep pads, tape, and other tools necessary for safely inserting an IV line. In this particular case, the non-sterile version of the kit contains two specific antiseptic applicators: BD ChloraPrep Clear in a 1 mL volume and FREPP Clear in a 1.5 mL volume. These applicators are commonly used to clean the skin prior to needle insertion to reduce the risk of infection.
The recall is strictly limited to one specific lot number to ensure that only affected products are addressed, minimizing disruption for healthcare providers who use other batches without issue. The impacted lot is number 1658438, which carries an expiration date of July 31, 2026. For precise identification and tracking purposes, the Unique Device Identifier (UDI) associated with this recalled product is 10809160460481. It is critical for hospitals, clinics, and individual purchasers to verify that the lot number on their inventory matches this specific identifier. If a facility has stock of the Halyard IV Start Kit Non-Sterile REF: KRIV26-02 with lot 1658438, those items are subject to this recall notice.
Regarding the timeline and geography of the distribution, the FDA reports that these kits were distributed nationwide within the United States. However, the specific data provided in the recall record highlights distribution in the state of Nebraska as a key area where these units were sold or delivered. The official recall date for this action is July 14, 2026. This means that any sales or distributions prior to this date may still be in circulation and should be checked immediately. While the distribution pattern notes Nebraska, the classification of the product as a Class II device indicates a moderate risk to health, necessitating clear communication to all potential users across the supply chain. Healthcare professionals must inspect their current stock against these specific details—brand, reference number, lot number, and expiration date—to determine if they possess any of the recalled units.
The hazard, explained
At the heart of this FDA Class II recall is a subtle but critical failure in the packaging integrity of the AVID Medical Halyard IV Start Kit (Non-Sterile, REF: KRIV26-02). The specific issue lies within the BD ChloraPrep Clear (1 mL) and FREPP Clear (1.5 mL) Applicators included in these kits. These products are designed to be sterile medical devices, meaning they must be free from any living microorganisms such as bacteria, viruses, or fungi before they reach the patient. Sterility is typically maintained by a sealed barrier that protects the contents until the moment of use. In this instance, however, wrinkles have formed in the paper lidding—the protective outer layer of the packaging. These wrinkles are not merely cosmetic defects; they physically compromise the seal area.
When the paper lidding wrinkles, it creates micro-tears or gaps in what should be an airtight and sterile barrier. This breach allows environmental contaminants to penetrate the package during storage, transport, or handling. Once the seal is breached, the applicator tips are no longer guaranteed to be sterile. While the kit is labeled "Non-Sterile," the specific inclusion of these particular antiseptic applicators implies a standard of cleanliness required for safe medical application, especially when used in conjunction with other sterile procedures or by healthcare professionals who rely on the sterility assurance of individual components within a convenience kit.
The danger here is rooted in the mechanics of infection transmission. When a non-sterile applicator touches a patient’s skin, particularly near an intravenous (IV) insertion site, it can introduce pathogens directly into the body. The skin is our primary defense against infection, but IV sites bypass this natural barrier entirely. If the applicator carries bacteria from compromised packaging, those microbes can enter the bloodstream. This is especially concerning because antiseptic wipes are often used to prepare a site *before* an invasive procedure. Using a contaminated wipe defeats the purpose of antisepsis and may actually increase the risk of introducing infection at the precise moment the skin needs to be cleanest.
In a clinical setting, this type of hazard can lead to local infections at the IV site or, in more severe cases, systemic infections such as bacteremia. While the recall notice does not report any specific incidents of harm yet, the potential for injury is significant because the failure mode—wrinkled paper lidding—is unpredictable and difficult to detect without close inspection. The breach is internal to the package structure, meaning a user might assume the product is safe simply because the outer box appears intact. This hidden nature of the defect makes it particularly insidious, as healthcare providers and patients may proceed with use under the false assumption that sterility assurance has been maintained.
Understanding this mechanism highlights why the FDA classifies this as a Class II recall. It is not the most severe classification (Class I), which is reserved for situations where there is a reasonable probability that the product will cause serious adverse health consequences or death. However, Class II indicates that use of the product could cause temporary or medically reversible adverse health effects. The breach in sterility assurance represents a clear deviation from safety standards, turning a tool meant to prevent infection into a potential vector for it. The physical defect—wrinkles in the paper lidding—is the direct cause, but the consequence is the loss of the protective barrier that ensures medical safety.
Who is most at risk
To understand who is truly vulnerable in this recall, we must first look at the nature of the product itself. The AVID Medical Halyard IV Start Kit (Non-Sterile) REF: KRIV26-02 is not a consumer good you might find on a home shelf or in a child’s toy box. It is a specialized medical device intended for professional use, specifically within clinical settings such as hospitals, urgent care clinics, and physician offices across the United States, with this particular distribution pattern noted in Nebraska and Virginia. Therefore, the primary group at risk is not the general public, but rather patients who are receiving intravenous (IV) therapy from healthcare providers who may have received the affected lots.
The specific hazard here stems from a manufacturing defect: wrinkles in the paper lidding of BD ChloraPrep Clear and FREPP Clear Applicators that lack sterility assurance. In medical terms, "sterility assurance" is not just a technicality; it is the absolute guarantee that no living microorganisms are present. When the seal area is breached by these wrinkles, the pathway for bacteria, fungi, or other pathogens to contaminate the antiseptic solution is opened. Consequently, the individuals most at risk are those whose immune systems are compromised and who rely on this product to prevent infection during a procedure that breaks the skin barrier.
This includes patients undergoing long-term IV treatments, such as chemotherapy for cancer, dialysis for kidney failure, or antibiotic therapy for severe infections. For these individuals, their bodies may already be struggling to fight off existing illnesses, making them highly susceptible to secondary infections if the antiseptic used to clean the skin before needle insertion is contaminated. Even a minor skin infection can escalate rapidly into a systemic issue, such as sepsis, in someone with a weakened immune response.
Additionally, elderly patients and very young children are often more vulnerable to the consequences of any medical complication. Their physiological reserves may be lower, meaning they might not tolerate an unexpected infection or adverse reaction as well as a healthy adult. While the recall notice does not specify injury incidents, the theoretical risk is highest for anyone who receives an IV start using this specific kit from Lot Number 1658438 (expiration date 7/31/2026). Healthcare providers and facilities are the first line of defense here; by identifying and removing these kits, they protect their most fragile patients from a preventable source of contamination. If you or a loved one is currently undergoing IV treatment, this is less about personal ownership and more about ensuring your care team is aware of and has addressed this specific supply chain issue.
How to tell if you have the recalled item
Identifying whether your medical supplies are part of this specific FDA recall requires a careful, methodical check of your inventory. Because the affected product is a specialized medical device rather than a generic consumer good, it will not be marked with a bright red "RECALL" sticker or a warning label on the outside of the box. Instead, the evidence you need to look for is printed directly on the packaging in the form of specific alphanumeric codes and lot numbers. You must physically locate the product and inspect the labeling closely to confirm its identity.
First, verify the brand and product name. The recalled item is the Halyard IV Start Kit Non-Sterile, manufactured by AVID Medical, Inc. Look for these exact words on the primary packaging. It is crucial to distinguish this from sterile versions of similar kits; this specific recall applies only to the Non-Sterile variant. Next, you must find the Reference number (REF). The recalled kit will clearly display REF: KRIV26-02. If your kit has a different REF number, it is not part of this specific batch and does not need to be returned under this notice.
The most critical piece of information for identification is the Lot Number. You must locate the lot number printed on the package. The recall specifically targets kits with Lot Number 1658438. If your kit has any other lot number, it is not affected by this safety notice. Alongside the lot number, check for the Unique Device Identifier (UDI). The recalled items will have a UDI of 10809160460481. This long string of digits is often found near the barcode or in a separate data field on the label. Having this UDI handy can help you verify the product against official FDA databases if you are unsure.
Additionally, pay attention to the expiration date printed on the packaging. The recalled lots expire on 7/31/2026. While an expiration date alone does not confirm a recall, the combination of the correct REF number, Lot Number 1658438, and this specific expiration date confirms you have the hazardous item. Note that while the distribution pattern indicates these items were distributed nationwide in the state of Nebraska, and the agency record lists Virginia (VA), you should check your purchase records or storage location to see if they originated from these areas, though the lot number is the definitive identifier regardless of where you bought it.
If you find a kit that matches all these criteria—the Halyard IV Start Kit Non-Sterile, REF KRIV26-02, Lot 1658438, UDI 10809160460481, and expiration 7/31/2026—you have the recalled item. Do not use it for patient care. The hazard involves wrinkles in the paper lidding of the BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators contained within the kit, which may breach the seal area. This lack of sterility assurance is the core reason for the identification steps above. Please stop using these kits immediately and contact the manufacturer or your supplier for further instructions on return or disposal, as the remedy details are not explicitly stated in this recall notice.
What to do — step by step
If you are in possession of the recalled Halyard IV Start Kit Non-Sterile manufactured by AVID Medical, Inc., your immediate priority is to ensure that this specific product does not enter any clinical or personal workflow. Because the official recall announcement from the U.S. Food and Drug Administration (FDA) issued on July 14, 2026, does not explicitly state a specific remedy such as a mandatory return for refund, a repair process, or a direct replacement protocol, you must rely on standard safety containment procedures. The lack of a stated remedy in the public notice means that the primary actionable step is isolation and verification rather than an automatic reimbursement process. Do not attempt to use these kits for any purpose, regardless of how minor the task may seem.
- Stop Use Immediately: If you have this kit in your inventory, whether in a hospital supply room, a clinic storage area, or even if you purchased it for home care, cease all use immediately. The hazard involves wrinkles in the paper lidding that may breach the seal area of the FREPP Clear 1.5 mL Applicators. This lack of sterility assurance means that the internal components could be contaminated with microorganisms, posing a significant infection risk to patients. Even if the package looks intact to the naked eye, the structural integrity of the sterile barrier cannot be guaranteed by visual inspection alone.
- Verify Your Inventory Details: Before taking any further action, you must confirm that your units match the specific criteria of this recall. The recall applies exclusively to the Halyard IV Start Kit Non-Sterile with Reference Number (REF) KRIV26-02. You must check the lot number, which is identified as 1658438, and verify the expiration date of 7/31/2026. Additionally, confirm the Unique Device Identifier (UDI), which is 10809160460481. If your items do not match these exact identifiers, they are likely not part of this specific Class II recall, though general caution with any compromised packaging is always advised.
- Contact the Manufacturer or Distributor: Since the FDA notice does not provide a direct remedy, you need to reach out to AVID Medical, Inc., or the authorized distributor through whom you purchased the item. Inquire about their specific internal recall procedures. They may offer disposal instructions, credit, or replacement for affected lots. Keep your purchase receipts and any documentation of the lot numbers handy during this conversation.
- Securely Dispose of the Product: If the manufacturer instructs you to discard the items, follow standard biohazard waste protocols if the kits have been opened or if they are considered contaminated due to the potential breach. If they remain unopened but compromised by the lidding defect, treat them as potentially infectious until proven otherwise. Do not return them to general recycling or trash bins without proper containment.
Remember that this is a Class II recall, which indicates a situation where use of the product could cause temporary or medically reversible serious injury to the patient. By acting quickly and verifying your stock against the specific REF and lot numbers, you protect patients from potential healthcare-associated infections. If you are unsure about the status of your inventory, err on the side of caution and consult with your facility’s infection control team or medical director for guidance.
Your refund, repair, or replacement options
When you encounter a product recall, the most immediate and practical concern is often how to resolve the issue without incurring additional costs or facing unnecessary hassle. In this specific instance involving AVID Medical, Inc., the FDA has classified this as a Class II recall due to sterility concerns with the Halyard IV Start Kit Non-Sterile. While the official recall documentation provided for this event does not explicitly state the specific remedy—such as whether you will receive a full refund, a replacement kit, or a repair instruction—it is standard practice in medical device recalls of this nature to offer a complete resolution at no cost to the consumer. The primary goal of any manufacturer or distributor in this situation is to remove the unsafe product from circulation and ensure that healthcare providers or end-users are not financially penalized for a manufacturing defect they did not cause.
Because the record indicates that the remedy is "not stated," it is crucial to understand that silence on the specific financial remedy does not mean you are left without options. In cases where the specific terms are not publicly detailed in the initial recall notice, the standard procedure involves contacting the responsible party directly to negotiate a resolution. For this recall, the distribution pattern notes that the kits were distributed nationwide but specifically highlights the state of NE (Nebraska) and includes a reference to VA (Virginia), suggesting that the administrative handling may be managed through specific regional channels or the manufacturer’s central customer service department. You should not assume that you must purchase new supplies out of pocket while waiting for clarification; rather, you are entitled to seek clarity on how your investment will be protected.
To secure your refund, replacement, or credit, you must act as the initiator of the resolution process. Since the recall involves a specific lot number (1658438) and a unique UDI (10809160460481), you will need to have this information ready when you reach out. These identifiers are your proof of purchase and your key to unlocking the remedy. When you contact AVID Medical, Inc., provide these details clearly. Explain that you possess a Halyard IV Start Kit Non-Sterile (REF: KRIV26-02) from the affected lot. Ask specifically about their current policy for this recall event. Will they send a sterile replacement kit? Will they issue a credit to your account? Will they arrange for a pickup of the non-compliant units? The "why" behind this process is simple: the manufacturer bears the liability for the breach in sterility assurance caused by the wrinkles in the paper lidding, and they are responsible for correcting the financial impact on their customers.
If you are a healthcare provider or institution, your internal procurement or risk management team should handle the logistics of returning the bulk inventory. They should request a Return Merchandise Authorization (RMA) number from AVID Medical to ensure the items are tracked correctly and that your facility’s financial records remain balanced. For individual consumers, if you purchased this item for personal use in Nebraska or Virginia, keep your receipt and the product packaging intact until the remedy is confirmed. Do not discard the kit yet, as it may need to be returned for inspection or proper disposal depending on the manufacturer's instructions. The lack of a stated remedy in the public record does not negate your right to a fair resolution; it simply means you must take the step to contact the company to activate that process.
What can happen if you ignore it
When a medical device recall involves sterility assurance issues, the stakes are rarely about the product simply failing to work; they are about introducing invisible threats into a vulnerable part of the body. In this specific case involving the AVID Medical Halyard IV Start Kit, the core problem is that wrinkles in the paper lidding may have breached the seal area for the BD ChloraPrep Clear and FREPP Clear applicators. This means the contents are no longer guaranteed to be sterile. Ignoring a sterility breach is not merely a procedural oversight; it creates a direct pathway for microbial contamination.
The most immediate risk of continuing to use these non-sterile applicators is the introduction of bacteria, fungi, or other pathogens directly into the patient’s bloodstream or subcutaneous tissue. Intravenous (IV) access points bypass the body’s primary defense system—the skin—making them a high-risk entry point for infection. If the ChloraPrep or FREPP solution has been compromised by moisture or air leaking through the wrinkled lidding, it may no longer effectively kill surface bacteria on the skin. More critically, if the applicator itself is contaminated, you are essentially painting germs onto a wound site right before inserting a catheter. This can lead to local infections at the IV site, characterized by redness, swelling, warmth, and pain.
Beyond local irritation, the consequences can escalate to systemic issues. Bacteria entering the bloodstream through an compromised IV line can cause bacteremia or sepsis, a life-threatening response to infection that affects the entire body. For patients who are already immunocompromised, elderly, or critically ill, even a minor contamination event can trigger severe complications requiring hospitalization, broad-spectrum antibiotics, or extended care. While the FDA recall notice does not currently list specific reported injuries or incidents for this lot, the potential for harm is well-documented in medical literature regarding breached sterile barriers.
It is important to understand that "non-sterile" does not mean "dirty" in a visible sense. You cannot see bacteria with the naked eye. A wrinkle in the packaging might look minor, but it can allow microscopic contaminants to pass through the barrier over time or during storage. By using this kit, you are gambling with the integrity of a medical intervention designed to be safe and clean. The convenience of having a "kit" does not outweigh the critical need for aseptic technique in clinical settings. Continuing to use these items ignores the fundamental principle of medical safety: do not introduce potential pathogens into sterile body spaces.
- Local Infection: Redness, pus, or fever at the IV insertion site.
- Systemic Infection: Sepsis or bacteremia, which can lead to organ failure.
- Treatment Delays: Additional medical interventions, longer hospital stays, and increased healthcare costs.
If you have these kits in your inventory, the safest course of action is immediate discontinuation. Do not assume that because the package looks intact on the outside, the interior seal is truly secure. The wrinkles are a known defect that compromises that very assurance. Protect your health and your patients’ health by removing these items from use immediately.
Staying safe: broader tips
While specific product recalls are necessary tools for public safety, they represent only one layer of a much larger strategy for maintaining health and wellness in your home and daily life. When dealing with medical devices, consumables, or any equipment intended to support your physical well-being, proactive vigilance is far more effective than reactive correction. The most fundamental habit you can cultivate is regular engagement with official safety databases. Rather than waiting for a crisis or a news alert, make it a quarterly routine to check the U.S. Food and Drug Administration (FDA) website and the Consumer Product Safety Commission (CPSC) database. These resources provide real-time updates on recalls that may affect products you already own but haven't used recently. By keeping your awareness active, you transform passive consumption into informed stewardship of your health tools.
Equally important is how we store and handle medical supplies once they arrive. Many hazards associated with medical kits, such as breaches in sterility or packaging integrity, can be exacerbated by improper storage conditions. Always keep medical devices and consumables in their original packaging until the moment of use. This preserves the manufacturer's sterility assurance and protects against environmental factors like humidity, dust, or temperature fluctuations that can degrade materials over time. If you must transfer items to a secondary container for organization, ensure it is clean, dry, and clearly labeled with expiration dates. Never store medical supplies in areas prone to moisture, such as under sinks, or in direct sunlight, which can weaken adhesives and plastics. Proper storage is a simple, non-invasive way to extend the functional life of your safety equipment.
Furthermore, consider establishing a "safety inventory" mindset. Unlike food items that are consumed regularly, medical devices often sit unused for long periods, making it easy to forget their expiration dates or recall status. Create a dedicated shelf or drawer for these items and attach a simple log sheet next to it. Note the date of purchase and the expected expiration. This visual cue serves as a gentle reminder to inspect your stock during seasonal cleaning routines. Additionally, register your medical devices with the manufacturer when possible. While not always mandatory, registration allows companies to contact you directly if a batch-specific issue arises, giving you a head start on any necessary precautions or replacements.
Finally, remember that safety is a shared responsibility between manufacturers and users. If you notice any irregularities in packaging, such as wrinkles in lidding, unusual odors, or damaged seals, do not assume it is safe to use the product anyway. Err on the side of caution and contact the manufacturer or distributor immediately. By staying informed, storing products correctly, and trusting your instincts when something feels off, you create a robust personal safety net that complements official recall efforts.